-inc-logo-1200x675.png){kind=logo}
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price reached a new 52-week high during trading on Thursday . The company traded as high as $11.88 and last traded at $11.64, with a volume of 36971 shares changing hands. The stock had previously closed at $11.68.
WuXi Biologics (Cayman) Trading Up 2.8%
The company’s 50-day simple moving average is $9.37 and its two-hundred day simple moving average is $9.18.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Featured Articles
- Five stocks we like better than WuXi Biologics (Cayman)
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
-inc-logo-1200x675.png){kind=logo}
